top of page
The Sage Group is attending Bio Partnering at JPM in
San Francisco from
January 12-15, 2026! Please click here to meet!
See Latest News!
GLOBAL LIFE SCIENCES DEALMAKERS: 30+ YEARS. 300+ CLIENTS & TRANSACTIONS. BILLIONS IN VALUE.
The Sage Group
Why Sage?
About
Track Record
Locations
Added Value
Sage Clients
Testimonials
SAGEIQ
Services
M & A
Licensing
Sage Global
Sage APAC
Sage China
Sage Japan
Sage India
Team
Meet Us!
News
Downloads
Contact
More
Use tab to navigate through the menu items.
Sage Group News
Opportunity to License or Acquire ES-3000, An Orphan Drug for CML and AML
Escend Therapeutics (www.escendpharma.com) is based in San Diego, CA, and develops small molecule therapeutics for oncology orphan drug...
Sage Group Advises APR on InLicensing and Acquisition of Novel Pharma Products
ABOUT APR Applied Pharma Research s.a. (www.apr.ch; “APR” or the “Company”) is a profitable, well-financed, privately held, Swiss...
Sage Advises Solasia on a Global Partnership for Darinaparsin, a Novel Treatment for Peripheral T Ce
Solasia has engaged The Sage Group to manage a program to establish a global partnership regarding licensing of its Darinaparsin product...
Sage Represents Luzitin in Licensing of its Redaporfin Combination Therapy for Solid Tumours
Sage represents Luzitin (www.luzitin.pt) to develop a strategic alliance for its Redaporfin PDT combination therapy for solid tumours....
Isofol Appoints The Sage Group to Identify Strategic Partnerships for its Novel Modufolin® Chemother
Isofol (www.isofolmedical.com), a clinical stage pharmaceutical company based in Gothenburg, Sweden, announces that following an...
CNSystems Appoints the Sage Group to Identify Strategic Partnerships for its Non Invasive Hemodynami
Graz, Austria, Cambridge UK, and Clinton NJ – January 2015 – CNSystems announces that following an internal strategic assessment, it has...
5
6
7
8
9
bottom of page
%20(2).jpg)
